ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
about
The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challengesRole of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular controlBrain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertensionTherapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionThe angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophyAngiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibitionAngiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failureRegulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assaysAngiotensin-converting enzyme 2: the first decade.Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertensionPerinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats.A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosisNeuroimmune communication in hypertension and obesity: a new therapeutic angle?MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptidesRegulation of ACE2 in cardiac myocytes and fibroblasts.Angiotensin-converting enzyme 2 and the kidney.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureAngiotensin converting enzyme 2 in the kidney.Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.Angiotensin-converting enzyme 2 in the brain: properties and future directions.Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heartThe sweeter side of ACE2: physiological evidence for a role in diabetes.Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive ratsNew frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.Designing heart performance by gene transfer.Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.
P2860
Q26823573-EFB6B200-FF5F-4CEE-AA19-321138CA0CFBQ28081615-782CDE1C-280F-4F9A-921A-3D003051A90DQ33639490-3F74DEFD-11A8-4506-A6AF-6AE619377B11Q33677369-5F060203-F3E6-47EC-8602-773956EE5836Q33684855-9EA0574B-5BD6-4F0E-A701-3DA106699372Q33795353-00988C2D-D5BB-44B8-B2D1-A0FBC80A5316Q34268946-FCA04286-F892-407D-944B-3698D647D115Q34423315-00E3025E-3853-46AB-AB20-D021F809CB2FQ34479181-700F204D-EBBA-44AC-AE41-B73E1A9BC19AQ34500735-AD91B680-85B7-4890-B739-CAA51290BB14Q34510691-2664A086-20DA-470B-847D-7BF9C813D745Q34799585-54B832A9-D771-4534-89AC-BB7A4FB57BF5Q34892110-EB559E3E-F0C5-4441-B635-37E0964B2736Q35217354-BE1E39C9-C204-41F1-817F-1A1A0C9A735FQ35251166-BEFF8907-5783-4F10-BCD5-F7B115E1FB5CQ35543390-4992C0AA-3DE1-4B12-9BBC-352FDBE86372Q35550937-2D3F074D-A33B-4184-8068-8B1103A7E35EQ35707198-B0E27F57-E6D3-401F-B290-0644D0346D3BQ35726197-D7F38F56-7386-4B25-86F3-AC8B864F3D85Q35776364-5CF5B90F-7AFE-4796-8E1F-5C95B379A9B1Q35995112-1A40FCF0-EB7B-48A4-AD3C-8280102EB5C1Q36033367-2B428B32-D32F-4CC7-8184-F6E1EA77F13EQ36739375-BEF137AB-7984-4BC6-86C5-6C5B1B1EDD88Q36808001-6E5BFE6F-D197-474A-873A-7E9B340F453BQ36824063-D6FF562E-D106-4E43-9B6E-C119B5733726Q36977764-AC6DBA10-05DB-40A6-9319-9DEAFBFD7B5EQ37038738-B3A33EB9-BF6A-4B2D-95F7-4EA74376C50BQ37068454-32560BD5-5C69-4420-84FE-A126F893697EQ37081415-3768ECF1-4079-4CCD-B06C-3B47B6F18FA9Q37097117-D8FD1202-00D3-47A7-944A-FB780587E184Q37127739-100E61F3-5B8A-4FF3-8B44-D7D926263C4EQ37155907-4C0A4B1A-306B-40A5-BE43-6BA5E02AEEE9Q37162741-137ACC92-40AE-4D8C-B6B8-6535BFF8879DQ37175696-9EC33B44-E9B9-4A07-963C-7C2BEB0BD1B3Q37178255-7DA2C39C-1E17-46F0-9944-9C9DA32A45BBQ37183375-F3229022-1872-48AB-9369-9E620E8AAA63Q37293326-13528B5B-393A-4C50-8D74-BF2B2D17A7DBQ37299072-FB2A1BB4-5008-4993-80F7-7870BCA4B879Q37608588-CBEA28BD-1418-47C1-93F1-01819DDA6266Q37660786-D71DA812-76E1-476D-BFEC-2605CF8282D3
P2860
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@en
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@nl
type
label
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@en
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@nl
prefLabel
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@en
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@nl
P2093
P2860
P1476
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
@en
P2093
Carlos Díez-Freire
Jorge Vázquez
Lihui Yuan
María F Correa de Adjounian
Merari F R Ferrari
Mohan K Raizada
Raquel Torres
Xeve Silver
P2860
P356
10.1152/PHYSIOLGENOMICS.00312.2005
P577
2006-06-20T00:00:00Z